Die Anamneseboegen stehen zum kostenfreien Download bereit: Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesisch, Englisch, Farsi, Franzoesisch, Griechisch, Italienisch, Japanisch, Kurdisch, Paschtu, Persisch, Polnisch, Portugiesisch, Rumaenisch, Russisch, Serbisch, Somali, Spanisch, Tigrinya, T...uerkisch, Urdu, Vietnamesisch
more
Die Anamneseboegen stehen zum kostenfreien Download bereit:
Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesisch, Englisch, Farsi, Franzoesisch, Griechisch, Italienisch, Japanisch, Kurdisch, Paschtu, Persisch, Polnisch, Portugiesisch, Rumaenisch, Russisch, Serbisch, Somali, Spanisch, Tigrinya..., Tuerkisch, Urdu, Vietnamesisch
more
Die Anamnesebögen stehen zum kostenfreien Download bereit:
Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesisch, Englisch, Farsi, Franzoesisch, Griechisch, Italienisch, Japanisch, Kurdisch, Paschtu, Persisch, Polnisch, Portugiesisch, Rumänisch, Russisch, Serbisch, Somali, Spanisch, Tigrinya..., Türkisch, Urdu, Vietnamesisch
more
Die Anamneseboegen stehen zum kostenfreien Download bereit: Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesisch, Englisch, Farsi, Franzoesisch, Griechisch, Italienisch, Japanisch, Kurdisch, Paschtu, Persisch, Polnisch, Portugiesisch, Rumaenisch, Russisch, Serbisch, Somali, Spanisch, Tigrinya, ...Tuerkisch, Urdu, Vietnamesisch
more
Erleichtert durch die Übersetzung der relevantesten Fragen die Erstanamnese einer fremdsprachigen Patientin durch den Gynäkologen/ die Gynäkologin. In Arabisch und Farsi. Weitere Übersetzungen in Vorbereitung
AWMF Leitlinie, 12.7.2021
Eine Leitlinie “Long-/Post-COVID-Syndrom" für Betroffene, Angehörige, nahestehende und
pflegende Personen, die sich auf eine ärztliche Leitlinie stützt („S1-Leitlinie Long-/Post-COVID“
der AWMF; Registernummer 020 - 027)
Erste Ausgabe September 2021
Comirnaty® 10 μg und 30 μg von BioNTech / Pfizer und Spikevax® von Moderna
(Comirnaty® 10 мкг або 30 мкг виробництва BioNTech/Pfizer та Spikevax® виробництва Moderna);
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit mRNA-Impfstoffen –
(Comirnaty® 10 μg bzw. ...30 μg von BioNTech/Pfizer und Spikevax® von Moderna)
more
– векторною вакциною – (Janssen® від COVID-19 виробництва Janssen Cilag International/Johnson & Johnson)
Anamnese zur Schutzimpfung gegen COVID-19 (Corona Virus Disease 2019) (Grundimmunisierung und Auffrischimpfungen)
– mit Vektor-Impfstoff – (COVID-19 Vacc...ine Janssen® von Janssen Cilag International/Johnson & Johnson)
more
Die Anamneseboegen stehen zum kostenfreien Download bereit: Albanisch, Amharisch, Arabisch, Bulgarisch, Chinesisch, Englisch, Farsi, Franzoesisch, Griechisch, Italienisch, Japanisch, Kurdisch, Paschtu, Persisch, Polnisch, Portugiesisch, Rumaenisch, Russisch, Serbisch, Somali, Spanisch, Tigrinya, ...Tuerkisch, Urdu, Vietnamesisch
more
In January 2021, the World Health Organization (WHO) published a new road map to address the burden of disease and death imposed by neglected tropical diseases (NTDs). The end of the first year of the 2021-2030 NTD road map is an opportunity to take stock of where we stand and how we plan to move fo...rward.
Considerable progress has been made since 2012 when the first road map was adopted. As of 6 June 2022, forty-six countries have eliminated at least one NTD, while 600 million people no longer require treatment because they are no longer exposed to risks associated with the pathogens that previously harmed them. In some cases, diseases that have plagued humanity for centuries, such as sleeping sickness and Guinea worm disease, are at an all-time low. Less tangible, but also important, there has been significant progress in the way NTDs are viewed. Additionally, the disruptive impact of the COVID-19 pandemic on NTD programmes is evident.
This brochure is the first in a series of advocacy briefs for the new NTD road map presenting highlights of success and challenges towards attaining the 2030 goals.
more
January 30, 2020 is the first-ever World Neglected Tropical Diseases Day (World NTD Day), a day when we celebrate the achievements made towards control of the world’s NTDs, yet recognize the daunting challenges we face in the control and elimination of these conditions.
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...rica [1, 2], but currently the exact distribution remains unclear. Reported prevalences of T. solium taeniosis and cysticercosis in African countries are not extensive and are further complicated by the lack of ‘gold standard’ tests for diagnosis.
more
Accessed on 22.04.2023
To target helminth elimination, a new consortium of research institutes, universities, not-for-profit organizations, and pharmaceutical companies have joined forces and expertise to establish a research and development pipeline for the development of anthelminthics targeti...ng nematodes. The focus is on STH as well as onchocerciasis.
more
MOBILISIERUNG INLÄNDISCHER ÖFFENTLICHER RESSOURCEN FÜR GESUNDHEIT
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region was certified free of wild poliovirus. In the area of... neglected tropical diseases, Guinea worm disease is on the verge of eradication, and 12 member states are within reach of being certified as having eradicated yaws by the end of this year.
more
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the... 3906 notified TB patients were tested for RR-TB and only 12 lab confirmed RR-TB patients were initiated on standard MDR-TB treatment of 20-months duration, (a 3-fold increase in RR-TB detection compared with 2017). This amounts to treatment coverage of only 17% of 72 estimated MDR/RR-TB among notified TB patients (3906) and 5% of 240 estimated incident MDR-TB patients as compared to 62% treatment coverage of 6300 incident drug sensitive TB patients estimated in TLS. The treatment success in the 2016 annual cohort of 6 MDR-TB patients has been reported at 83%. 80% of TB patients know their HIV Status with around 1% TB-HIV co-infection, 37/ 77 (48%) TB-HIV Co-infection Detected. Of the 387 PLHIV currently alive on ART, exact status on TB screening and testing is unknown. % of PLHIV newly enrolled in HIV care who received IPT is not known.
In 2018, the mortality rate for TB was 94 deaths per 100,000 people (1200 per annum) in TL with an increasing mortality trend (Figure 1), despite TB services being available for nearly two decades.
A survey of catastrophic costs due to TB (2016) highlights that 83% of TB patients are reported to be facing catastrophic costs due to the disease. This is the highest rate in the world.
more
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...cks progress made with respect to disease burden reduction, elimination and eradication. It also highlights major emerging threats, opportunities and priorities in the fight against commu- nicable and non-communicable diseases in the region. It covers the period 2000-2022, but for some indicators, information is available only up to 2021.
The report shows the number of reported cases for malaria and vaccine preventable diseases (meningitis, measles, yellow fever, pertussis, diphtheria, tetanus, and polio); disease incidence due to HIV, tuberculosis and four major noncommunicable diseases (cardiovas- cular diseases, cancers, diabetes and chronic respira- tory diseases).
more
Hey Facts about the disease